Epoetin Alfa Epbx

Save $5,733/mo

14× cheaper

RETACRIT is an erythropoiesis-stimulating agent (ESA) indicated for: • Treatment of anemia due to o Chronic Kidney Disease (CKD) in patients on dialysis and not on dialysis ( 1.1 ).

United States

$6,180

per month

India

$447

per month

You save

$5,733

93% cheaper in India

47.8K US scripts/yr$274.1M potential annual savings$295.4M US spend/yr

3D structure coming soon

Resolve it by running structure:fetch

Compare the price

US price$6,180per month

India price$447per month

You save$5,73393% less

Based on 30 units per month. US $205.99 vs India $14.90 per unit.

How many months / courses?

Total over 1 periodSave $5,733$6,180 → $447

Is travelling to India worth it?

The savings here are large enough that a trip may still come out ahead. Adjust the numbers to your own situation — every value is an editable estimate.

Months of medicine

Round-trip flights ($)

Hotel / night ($)

Nights of stay

Extra buffer ($)

Medicine savings over 6 months: $34,397
Estimated travel cost: − $2,300
Net savings after travel: $32,097

Even after travel, you could come out ahead by about $32,097.

Assumptions: medicine savings = (US − India monthly price) × months. Travel cost = flights + hotel × nights + buffer. Excludes consultation fees, visas, and other costs. For information only — not medical, legal, or travel advice.

The bigger picture

Epoetin Alfa Epbx is filled about 47.8K times a year under Medicare Part D. At the prices above, that works out to roughly:

Est. annual US spend

$295.4M

If sourced from India

$21.4M

Potential annual savings

$274.1M

−93%

Rough estimate. Based on Medicare Part D prescription volume (not the entire US market) scaled by the representative monthly price — actual totals depend on dose, duration and coverage.